Pharmacokinetics and Safety Study of Apetrol ES

• Status: Completed
• Trial end date: 2010-10-01

Summary

A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® in Healthy Male Volunteers.

• Phase: Phase 1

Details

• Lead Sponsor: LG Life Sciences
• Collaborator: Severance Hospital
• Treatments: Megestrol; Megestrol Acetate